Partner Headlines - XLV

  1. Regeneron, Amgen Downgraded As Biotech Seen Slowing

    IBD
  2. 4 ETF Strategists Weigh In On U.S., European Markets

    IBD
  3. Energy, TIPs And Biotechnology ETFs To Watch This Week

    Benzinga
  4. SPDR ETFs: Why Is State Street's Nick Good Excited About 2015?

    IBD
  5. Emerging Market Bond, Oil And Healthcare ETFs To Watch This Week

    Benzinga
  6. How To Plan An XLV Call Ratio Spread

    Benzinga
  7. Global X Launches Two New Rules-Based ETFs

    Benzinga
  8. Worried? Picks Of Mr. Cautious, 80% In Stocks

    YCharts
  9. Which Fund Has The Most To Gain From Biogen Idec?

    Benzinga
  10. ArrowShares Launches New Tactical ETF

    Benzinga
  11. What Do The Sectors Say About Technical Divergences?

    Benzinga
  12. Sigma-Aldrich Hits High On Sale To Germany's Merck

    IBD
  13. With Actively Managed Funds, Be Wary Of Expense Ratios

    Benzinga
  14. Build a "Whatever Happens" Portfolio - Now!

    GuruFocus
  15. Earnings Season Is The Right Prescription For Health Care ETFs

    Benzinga
  16. Standout In Pharma Supply Chain’s Growth Story

    YCharts
  17. Sell-In-May: Seasonal Winners and Losers Listed

    YCharts
  18. Growth Story: Fund Managers Buy Healthcare

    YCharts
  19. Biotech ETFs Come Back Down To Earth

    Benzinga
  20. Are Earnings Important? These Days, Revenues Count for More!

    GuruFocus
  21. Why Mr. Cautious Is 82% Invested In Stocks

    YCharts
  22. Sector ETFs Breaking Out (IBB, IHE, XLV, IAT, SKYY)

    Benzinga
  23. Health Care ETFs After Obamacare (IHF, XLV, UNH, ESRX)

    Benzinga
  24. These Industry ETFs Will Keep Soaring

    Benzinga
  25. Thinking of Investing with a Hedge Fund?

    GuruFocus
  26. Write A Prescription For Health Care ETFs

    Benzinga
  27. ETFs to Watch September 5, 2013 (EFA, TLT, XLV)

    Benzinga
  28. Rising Rates Could Make These ETFs Betray Seasonal Trends

    Benzinga
  29. Plenty Of ETFs With Favorable Risk Traits

    Benzinga
  30. S&P: Heaping Praise For Some Health Care ETFs

    Benzinga
  31. Three Soaring, But Overlooked Health Care ETFs

    Benzinga
  32. SPY: Banks Could be Boss Again

    Benzinga
  33. A Look Ahead: This Week's ETFs to Watch

    Benzinga
  34. Analyst Sees Tough Road Ahead For Fidelity Sector ETFs

    Benzinga
  35. ETFs to Watch February 11, 2013 (DEM, EWI, XLV)

    Benzinga
  36. China's Pollution Woes Could Boost These ETFs

    Benzinga
  37. 4 Health Care ETFs Your Broker Forgot to Mention

    Benzinga
  38. S&P Sees Better 2013 For Health Insurance Providers

    Benzinga
  39. S&P Reiterates Bullish View on Health Care ETFs

    Benzinga
  40. Medical Device ETFs Flash Bearish Technicals, Fundamentals Post-Obama ...

    Benzinga
  41. ETFs to Watch November 8, 2012 (BAB, QQQ, SLV)

    Benzinga
  42. More Pain Awaits Medical Device ETFs

    Benzinga
  43. ETFs to Watch November 7, 2012 (TLT, USO, XLV)

    Benzinga
  44. For a Post-Election Risk On Rally, Buy These ETFs

    Benzinga
  45. Best & Worst ETFs & Mutual Funds: Health Care Sector

    Benzinga
  46. How To Find the Best ETFs

    Benzinga
  47. Sector Rankings For ETFs & Mutual Funds

    Benzinga
  48. Rating Breakdown: Best & Worst ETFs & Mutual Funds by Sector

    Benzinga
  49. ETFs to Watch October 19, 2012 (QQQ, XES, YCS)

    Benzinga
  50. Post-Election, Keep an Eye on Mexico ETFs

    Benzinga
  51. Leveraged ETFs For October

    Benzinga
  52. Part I: Must Know ETFs For Q3 Earnings

    Benzinga
  53. Option Volume Briefs: Targeting Upside in the Healthcare Sector

    SchaeffersResearch
  54. These ETFs Could Soar Starting in October

    Benzinga
  55. S&P Highlights Election ETFs

    Benzinga
  56. S&P Still Bullish on Health Care ETFs

    Benzinga
  57. Low Volume, High Returns for These ETFs (BIB, FHC, DRW)

    Benzinga
  58. ETFs to Watch July 13, 2012 (ITB, TBT, ZSL)

    Benzinga
  59. ETFs to Watch July 9, 2012 (BOND, EPI, XLV)

    Benzinga
  60. Small-Cap Corner: A Forgotten Biotech ETF

    Benzinga
  61. ETFs to Watch June 28, 2012 (CURE, XBI, FCG)

    Benzinga
  62. Leveraged ETFs for the Obamacare Ruling

    Benzinga
  63. Ahead of Obamacare Ruling, S&P Likes Health Care SPDR

    Benzinga
  64. 4 More Leveraged ETFs Your Broker Forgot to Mention (BOIL, SDP, ...

    Benzinga
  65. 3 Sector ETFs with Upside Potential (LIT, PSCC)

    Benzinga
  66. Sneaky High: Some Sector ETFs Now Surprisingly Pricey

    Benzinga
  67. Goldman Highlights ETF Correlations (XLF, XLK, XLU)

    Benzinga
  68. An Interesting ETF Option for the Generic Drug Boom (RTH, XLV)

    Benzinga
  69. ETFs to Watch June 1, 2012 (XLV, JNK, KOL)

    Benzinga
  70. ETFs to Watch May 30, 2012 (XLV, EUO, HYD)

    Benzinga
  71. ETFs to Watch May 29, 2012 (XLV, BRF, EUO)

    Benzinga
  72. ETFs to Watch May 25, 2012 (XLV, HAO, HYD)

    Benzinga
  73. Health Care SPDR In Focus Ahead Of Obamacare Decision

    Benzinga
  74. 10 ETFs That Should Lower Their Expense Ratios

    Benzinga
  75. Grandpa's 2012 ETF Portfolio

    Benzinga
  76. ETFs to Watch February 10, 2012

    Benzinga
  77. AdvisorShares to Introduce Fund of Funds ETF Today

    Benzinga
  78. Inside: 2012's Best Value Investment

    Benzinga
  79. ETFs to Watch December 16, 2011

    Benzinga
  80. How Will Healthcare Reform Affect Your Investments?

    Benzinga
  81. Is Endo Pharmaceuticals Going to Seize Market Share?

    Benzinga
  82. Are You Guaranteed Profits if These Rumors are True?

    Benzinga
  83. Twelve For '12: Sector ETFs to Watch In The New Year

    Benzinga
  84. Is This Drug About to Cure Cancer?

    Benzinga
Trading Center
×

You are using adblocking software

Want access to all of Investopedia? Add us to your “whitelist”
so you'll never miss a feature!